These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34466139)

  • 21. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
    Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; de Zeeuw D; Eckardt KU; McMurray JJV; Claggett B; Lewis EF; Pfeffer MA
    Am J Kidney Dis; 2017 Oct; 70(4):522-531. PubMed ID: 28599901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-lowering for prevention of coronary heart disease: what policy now?
    Ul Haq I; Ramsay LE; Pickin DM; Yeo WW; Jackson PR; Payne JN
    Clin Sci (Lond); 1996 Oct; 91(4):399-413. PubMed ID: 8983865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Navigating the "MACE" in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefits.
    Hupfeld C; Mudaliar S
    Diabetes Obes Metab; 2019 Aug; 21(8):1780-1789. PubMed ID: 30957945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Status of cholesterol goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis].
    Li Y; Zhao SP; Ye P; Yan XW; Mu YM; Wei YD; Hu DY;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Aug; 44(8):665-70. PubMed ID: 27545124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Sodium-Glucose Cotransporter-2 Inhibition in the Treatment of Adults With Heart Failure.
    Sharma A; Ezekowitz JA
    Can J Diabetes; 2020 Feb; 44(1):103-110. PubMed ID: 31630988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure management.
    Sabouret P; Galati G; Angoulvant D; Germanova O; Castelletti S; Pathak A; Metra M; Margonato A
    Eur Heart J Cardiovasc Pharmacother; 2020 Nov; 6(6):394-404. PubMed ID: 32402065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trialogue Plus: Management of cardiovascular risk in hyperglycaemic/diabetic patients at hospital discharge.
    Beltramello G; Manicardi V; Mazzuoli F; Rivellese A;
    Acta Diabetol; 2013 Dec; 50(6):989-98. PubMed ID: 24121870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment.
    Andrés M; Bernal JA; Sivera F; Quilis N; Carmona L; Vela P; Pascual E
    Ann Rheum Dis; 2017 Jul; 76(7):1263-1268. PubMed ID: 28093417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial.
    McGuire DK; Van de Werf F; Armstrong PW; Standl E; Koglin J; Green JB; Bethel MA; Cornel JH; Lopes RD; Halvorsen S; Ambrosio G; Buse JB; Josse RG; Lachin JM; Pencina MJ; Garg J; Lokhnygina Y; Holman RR; Peterson ED;
    JAMA Cardiol; 2016 May; 1(2):126-35. PubMed ID: 27437883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What imaging techniques should be used in primary versus secondary prevention for further risk stratification?
    Schiele F; Navarese EP; Visoná A; Ray K
    Atheroscler Suppl; 2017 Apr; 26():36-44. PubMed ID: 28434483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing cardiovascular risk in chronic kidney disease patients prior to kidney transplantation: clinical usefulness of a standardised cardiovascular assessment protocol.
    Ramphul R; Fernandez M; Firoozi S; Kaski JC; Sharma R; Banerjee D
    BMC Nephrol; 2018 Jan; 19(1):2. PubMed ID: 29310598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of macrovascular complications in patients with type 2 diabetes mellitus: Review of cardiovascular safety and efficacy of newer diabetes medications.
    Kant R; Munir KM; Kaur A; Verma V
    World J Diabetes; 2019 Jun; 10(6):324-332. PubMed ID: 31231455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular risk factors control according to diabetes status and prior cardiovascular events in patients managed in different settings.
    Vaccaro O; Vitale M; Costanzo S; Masulli M; Riccardi G; De Curtis A; Donati MB; Rivellese AA; de Gaetano G; Iacoviello L
    Diabetes Res Clin Pract; 2020 Oct; 168():108370. PubMed ID: 32827595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
    Ferdinand KC; Botros FT; Atisso CM; Sager PT
    Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computed Tomography for Coronary Artery Calcification Scoring: Mammogram for the Heart.
    Qazi AH; Zallaghi F; Torres-Acosta N; Thompson RC; O'Keefe JH
    Prog Cardiovasc Dis; 2016; 58(5):529-36. PubMed ID: 26892393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
    Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention.
    Porath A; Arbelle JE; Fund N; Cohen A; Mosseri M
    Isr Med Assoc J; 2018 Aug; 20(8):480-485. PubMed ID: 30084572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice.
    Garber AJ
    Diabetes Obes Metab; 2002 Jan; 4 Suppl 1():S5-12. PubMed ID: 11843949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.